We used electrophysiological methods in a slice preparation to study the mechanisms of somatostatin (SS) effects on hippocampal pyramidal neurons. SS hyperpolarizes hippocampal pyramidal neurons in part by augmenting the timeand voltage-dependent M-current (I,), which has been shown to be reduced by muscarinic agonists.
The SS effects are abolished by the phospholipase A, inhibitors 4-bromophenacyl bromide and quinacrine. Arachidonic acid (AA) mimics all the effects of SS on hippocampal pyramidal neurons. The effects of AA and SS on I, are blocked by the lipoxygenase inhibitor nordihydroguaiaretic acid but not by the cyclooxygenase inhibitor indomethacin. Prostaglandins E,, F,,, and I, do not increase I,. However, the specific 5-lipoxygenase inhibitors 5,6-methanoleukotriene A, methylester and 5,6-dehydroarachidonic acid both blocked the /,-augmenting action of either SS or AA. Leukotriene C, (but not leukotriene B,) increases & to the same extent as AA. I, was not altered by the 12-lipoxygenase product 12-hydroperoxyeicosatetraenoic acid, and SS effects were not altered by the 12-lipoxygenase inhibitor baicalein. These data implicate 5-lipoxygenase metabolite(s) (probably leukotriene C,) as a mediator for the /,-augmenting effect of SS. In addition, when the IM effect is blocked by lipoxygenase inhibitors, both SS and AA elicit another outward current that is not blocked by either lipoxygenase or cyclooxygenase inhibitors, suggesting a direct role of AA itself distinct from the /, effect. SS did not alter significantly Ca2+-dependent action potentials or, in whole-cell recordings, inward currents likely to represent high-threshold Ca*+ currents. The combined results of these studies suggest that SS hyperpolarizes hippocampal neurons by two mechanisms, both mediated through the AA system. However, one mechanism (6) involves a metabolite of AA and is most effective at slightly depolarized potentials, whereas the other may involve AA itself and be more effective at membrane potentials near rest.
[Key words: hippocampus, somatostatin, arachidonic acid, phospholipase A, M-current, lipoxygenase, leukotrienes, voltage clamp] Somatostatin (SS; also SS-14, SRIF) is reported to be the second or third most abundant neuropeptide in most mammalian brain regions (Crawley, 1985) . In hippocampus, immunohistochemical studies have revealed many SS-containing interneurons and a profuse network of intrinsic and extrinsic SS-containing fibers that appear to project to pyramidal and granule neurons (see, e.g., Bakst et al., 1986; Joels et al., 1990) . In addition, behavioral and clinical findings suggest an important role for SS in cognitive functions (Epelbaum, 1986) . In spite of the apparent importance of SS in brain function, little is known of the exact physiological mechanisms of SS action. Results of early electrophysiological studies seemed to support a role for SS as an excitatory transmitter (Dodd and Kelly, 1978) . However, more recent in viva and in vitro studies in our laboratory (Pittman and S&gins, 198 1; Mantillas et al., 1986; Moore et al., ,1988; Schweitzer et al., 1990) and elsewhere (Watson and Pittman, 1988) support the view that SS is predominantly an inhibitory transmitter in the hippocampus. The inhibition of spike discharge is accompanied by a hyperpolarization associated with an increase in conductance to K+ ions, at least in part via augmentation of the M-current (Z,) (Moore et al., 1988; Watson and Pittman, 1988; Schweitzer et al., 1990) . SS also hyperpolarizes neurons in other brain areas by K+ mechanisms (Inoue et al., 1988; Jacquin et al., 1988; Twery and Gallagher, 1989; Wang et al., 1989) . Whereas SS-28, thought to be the preprohormone for SS-14, can act like SS-14 in some brain regions (S&ins et al., 1982; Jacquin et al., 1988; Moore et al., 1988; Watson and Pittman, 1988) , in others SS-28 elicits responses different from, or even opposite to (Wang et al., 1989) , those evoked by SS-14.
The I,,, is a time-and voltage-dependent K+ current that persists at slightly depolarized membrane potentials and is thought to clamp the membrane at potentials near rest (Brown and Adams, 1980; Adams et al., 1982) . ZM is reduced by muscarinic choline& agonists, certain peptides (e.g., leutinizing hormone-releasing hormone, substance P, bradykinin; for review, see Brown, 1988) , 5-HT, and the excitatory amino acid quisqualate (Charpak et al., 1990) , and by this mechanism is responsible in part for the slow and late-slow EPSPs in sympathetic neurons (Adams and Brown, 1982) . Hippocampal pyramidal neurons also exhibit an I,, which may be responsible, at least in part, for the slow muscarinic EPSP evoked in hippocampal neurons by short stimulus trains (Halliwell and Adams, 1982 ; but see Madison et al., 1987) . Recently, we reported that Ihl in hippocampal neurons in vitro was not only reduced by muscarinic agonists but markedly augmented by SS, suggesting that two different receptors can reciprocally regulate one neuronal channel type (Moore et al., 1988) . A similar reciprocal (The cvtochrome P-450 svstem is not shown for clarity.) The inhibitors used are 4BPB (4-bromophenacyl bromide), Quin (quinacrine), NDGA (nordihydroguaiaretic acid), Zndo (indomethacin), Bui (baicalein), MLTA (5,6-methanoleukotriene A, methylester), and DHAA (5,6-dehydroarachidonic acid) (for details on the drugs used and their specificity, see Blackwell and Flower, 1983; Higgs and Vane, 1983; Piomelli and Greengard, 1990 ). I, regulation, by ACh and isoproterenol, has been reported for smooth muscle cells (Sims et al., 1988) .
The slow time course of SS-induced inhibitions and its ability to modulate GTP-binding proteins (North, 1989; Law et al., 199 1) and the levels of second messengers (Schonbrunn, 1990) suggest involvement of some specific transduction systems in hippocampal SS effects. In sympathetic neurons, muscarinic reduction of ZM may be mediated through G-protein activation of phospholipase C (PLC), with subsequent generation of diacylglycerols and activation of protein kinase C (Brown et al., 1989) . By contrast, in hippocampal CA1 pyramidal neurons muscarinic inactivation of Z, may not require protein kinase C activation , but rather the inositol triphosphate side of the PLC cycle (Dutar and Nicoll, 1988 ). Another candidate for transduction is the CAMP system. Sims et al. (1988) recently showed that the augmentation of ZM by isoproterenol involves CAMP mediation in smooth muscle cells, and SS is known to modulate adenylate cyclase activity in brain (Chneiweiss et al., 1985; Wang et al., 1989) . The phospholipase A, (PLA,) pathway ( Fig. 1 ) is another source of mediators implicated in neuronal signal transduction (Piomelli et al,, 1987a) . This enzyme catalyzes the release of arachidonic acid (AA), yielding several eicosanoids via different metabolic pathways. Two major pathways for AA metabolism are (1) via cyclooxygenase (COX) to form prostanoids, and (2) via lipoxygenases (LOXs) to form hydroperoxyeicosatetraenoic acids (Needleman et al., 1986) . Some 12-lipoxygenase (12-LOX) products mediate or modulate the effects of the peptides FMRFamide and histamine on K+ channels in Aplysia neurons (Piomelli et al., 1987a,b) , and hyperpolarize hippocampal pyramidal neurons (Carlen et al., 1989; Pace-Asciak et al., 1990) . Metabolites of the 5-lipoxygenase (5-LOX) pathway alter spontaneous extracellular firing rate in rat cerebellar Purkinje cells in viva (Palmer et al., 198 1) and are involved in the opening of a G-protein-gated muscarinic K+ channel (Z,,A,,) in atria1 cells (for reviews, see Piomelli and Greengard, 1990; Shimizu and Wolfe, 1990) . AA itself and certain fatty acids also directly modulate K+ and other conductances in peripheral tissues (reviewed by Ordway et al., 199 1) .
We recently reported data suggesting that an AA metabolite, perhaps a leukotriene, mediates the ZM-augmenting effects of SS in hippocampal pyramidal cells (Schweitzer et al., 1990) . In the present studies, we report new data suggesting another hyperpolarizing action of SS possibly mediated by AA itself, and we confirm the involvement of 5-LOX metabolites in ZM augmentation. In addition, we now find little evidence for the effects of SS on other K+ conductances or on large inward currents in rat hippocampal pyramidal neurons.
Materials and Methods
Slice preparation. We used standard intracellular and whole-cell patchclamp recording techniques in the rat hippocampal slice, prepared as described previously (Pittman and Siggins, 1981; Moore et al., 1990) . In brief, transverse hippocampal slices (taken from male Sprague-Dawley rats of 100-170 gm body weight) 350-400 pm thick were cut on a brain slicer and incubated in gassed (95% O,, 5% CO,) artificial cerebrospinal fluid (ACSF) of the following composition (in mM): NaCl, 130; KCl, 3.5; NaH,PO,, 1.25; MgSO,.7H,O, 1.5; CaCl,, 2.0; NaHCO,, 24; glucose, 10. Other ions and agents were added to this ACSF medium. After a short incubation period in an interface configuration, the slices were completely submerged and continuously superlused with warm (30-3 1°C) ACSF at a constant rate within the range of 2.0-4.0 ml/min. However, in five of nine cells studied with the leukotrienes, the flow rate was decreased to about l-l.5 ml/min to ensure drug penetration into the slice, because their costliness dictated the use of small volumes. In this case, the slower flow rate was held constant throughout the recording period. The voltage-clamp studies were done at 30-31°C to slow down Zhl kinetics; however, in a previous study, SS superfusion at 35-37°C elicited the same augmenting effect on IM as at lower temperatures (Moore et al., 1988) . In most studies, we used sharp glass micropipettes filled with KC1 (3 M; tip resistances, 50-80 MQ) to penetrate CA1 pyramidal neurons. Methods of superfusion, voltage-clamp recording, cell identification, drug administration, and data analysis were as described previously (Pittman and Siggins, 198 1; Moore et al., 1988 Moore et al., , 1990 Schweitzer et al., 1990) .
Electrophysiological methods. Current-and voltage-clamp studies were performed with an Axoclamp preamplifier. In voltage-clamp mode, tetrodotoxin (0.5-l PM) was added to block synaptic transmission and Na+-dependent action potentials. In discontinuous single-electrode voltage-clamp mode, the switching frequency between current injection and voltage sampling was 3-4 kHz for intracellular recording. Electrode "settling time" and input capacitance neutralization at the headstage were monitored continuously on an oscilloscope (Finkel and Redman, 1985) . Current and voltage records were filtered at 0.3 kHz and usually acquired by D/A sampling and acquisition software @CLAMP, Axon Instruments). For I, studies, we most often applied -5, -10, -15, and -20 mV voltage commands in sequence three to five times for subsequent averaging. Current measures thus were derived from averages of three to five sweeps at each of the four voltage commands.
The various problems (e.g., space clamping) associated with voltage clamping of neurons with extended processes are discussed elsewhere (Halliwell and Adams, 1982; Johnston and Brown, 1983; Finkel and Redman, 1985) . These problems may be less acute when dealing with relative changes following drug application (see Madison et al., 1987) . Notwithstanding, we repeated some studies with SS in the presence of various pharmacological agents, to minimize the contribution of large non-K+ conductances (e.g., Na+ and Ca2+) in remote dendrites (see below). In some cells, we used whole-cell recording in a "blind" patchslice configuration (Blanton et al., 1989) with the membrane potential held throughout at -60 to -70 mV except for short command steps.
M-current analysis. In hippocampal CA1 pyramidal neurons, Ihl is best seen with holding potentials of -40 to -45 mV and hyperpolarizing command steps of 5-25 mV and durations of 700-1000 msec (Halliwell and Adams, 1982) . Here IM appears as a slow inward current "relaxation" following the instantaneous (ohmic) inward current drop ( Fig.  2A) . As the instantaneous current jump at command onset is larger than that at command offset, the relaxation represents the inactivation of an outward (K+ ) current rather than the activation of an inward current. I,,, amplitude was measured with software (CLAMPFIT, Axon Instruments) that fitted exponential curves (one exponent, r values = 0.95-0.99) to the IM relaxation. We used the difference between the instantaneous peak current at command onset and the steady-state current just before command offset to quantify the magnitude of Z, (see Fig. 2 ). Tail (offcommand) currents were not analyzed because of possible contamination with other currents. Usually, a current (capacitative) artifact of 5-20 msec duration was present at command onset (see also Halliwell and Adams, 1982) . Therefore, for estimation of the instantaneous portion of I, with hyperpolarizing commands, the current relaxation was fitted via two methods: (1) curve fitting to the peak of the initial (quasiinstantaneous) current (Fig. 2Aa ) that usually fell within 5-20 msec of step onset after complete settling of the capacity transient, or (2) exponential fitting through the peak with extrapolation to command onset ( Fig. 2Ab) , based on the finite duration of the initial capacitative artifact and the exponential (monotonic) nature of the I, relaxation. These methods gave essentially equivalent results with respect to relative effects of drugs, although the extrapolated I, amplitude was obviously bigger (lO-25%; average 20%) than amplitude at peak (Fig. 2B ). For statistical purposes the first method was used.
Q-current analysis. The Q-current (I,) is an anomalous or inward rectifier current carried by Na+ and K+ and seen in hippocampal pyramidal neurons (Halliwell and Adams, 1982) . Like ZM, it produces a slow inward current relaxation with hyperpolarizing voltage steps, although only from hyperpolarized holding potentials (more negative than -65 mV) and via activation of an inward current. The amplitude of the relaxation increases as a function of the command hyperpolarization. Zo and other forms of anomalous rectification were pharmacologically distinguished from I, by their differential sensitivity to extracellular cesium (2 mM; to block IQ) or the muscarinic agonist carbachol (CCh; 25 UM: to block I,).
positive agonist response was established. This protocol was feasible because, once initiated, the I, effect of SS or AA did not show desensitization over the complete testing period. In some cells, the antagonist was superfused alone to test possible effects on baseline properties. In a few other cells, the inhibitor was applied first (for 6-7 min), followed by addition of the agonist.
Somatostatin was obtained from Drs. J. Rivier and W. Vale at the Salk Institute and M. Buchmeier at The Scripps Research Institute. Arachidonic acid (AA, Sigma), hydroperoxy acids (Cayman Chemical), leukotrienes (Sigma), 5-LOX inhibitors (Biomol), and prostaglandins (Sigma) were stored at -80°C and used immediately after suspension; the lipids were dried under nitrogen and dissolved in the ACSF by sonication. Preparations of lipids showing precipitate or droplets after sonication (indicating lack of solution in the ACSF) were discarded. We dissolved nordihvdroguaiaretic acid CNDGA: Siama). 4-bromouhenacvl bromide (4BPB; -Sigma), baicalein (Biomol); aid leukotrienes in 0.1% dimethyl sulfoxide (DMSO), and AA in 0.25% DMSO. DMSO alone in the superfusion medium at the concentration used during our experiments had no significant effect on seven cells. However, we observed a small decrease in ZM and a small inward current slowly developing when testing 0.5% DMSO. Quinacrine (mepacrine, Sigma) was dissolved directly in the ACSF. Indomethacin (Sigma) was dissolved in ACSF containing 16 mM ethanol, which alone did not affect Z, (see Moore et al., 1990) . I-Bromo-CAMP (8-Br-CAMP), dibutyryl-CAMP, and carbachol (CCh) were obtained from Sigma; QX-3 14 was a gift of Astra Pharmaceuticals.
Results
We studied a total of 145 CA1 pyramidal neurons. These neurons had an average resting membrane potential (RMP) of -66.7 + 0.5 mV (mean * SEM) and action potential amplitude of 102 -t 0.6 mV (n = 87); mean resistance was 56 MQ (n = 72) at RMP. Stable recordings could be maintained for up to 4 hr, suggesting a relative lack of injury by the electrode penetration. We tested ZM using voltage clamp at holding potentials of -38 to -50 mV (mean, -42.7 -t 0.4 mV). The mean (outward) holding current reached at these depolarized potentials was 635 f 3 1 pA. The ZM relaxation was voltage dependent with a maximum amplitude of 70-150 pA (103 + 4 PA) in control condition, using commands of -5 to -20 mV.' Several lines of evidence suggest, as reported previously (Halliwell and Adams, 1982; Moore et al., 1988 ) that the relaxations represent Zhl: (1) the relaxations are suppressed (leaving only a "rectangular" ohmic current response) by the muscarinic agonists CCh or muscarine or by 1 mM Ba2+, (2) the current-voltage curves for the relaxations are shifted in a positive direction by an increase of K+ in the medium, (3) the magnitude, kinetics, and voltage dependence of the relaxations appear equivalent to those of the pyramidal cell M-current reported previously.
iarge inward &ductances and whole-cell patch clamp. In studies designed to minimize the possibility that the current relaxations measured were artifacts of large, non-K+ conductance changes (e.g., remotely in the dendrites), we injected a local anesthetic, Na+ channel blocker QX-3 14 (25-100 rnM in the recording pipette), while superfusing TTX (0.5-l PM) and CdCl, (50-300 PM) to block Na+ and Ca2+ currents. We verified the action of these agents in current-clamp mode by following the loss of current-evoked Na+-and Ca2+-dependent action potentials.
To assess the effect of SS on Ca*+ currents in CA1 pyramidal neurons, we used whole-cell voltage clamp ("blind patch slice"; see Blanton et al., 1989) in continuous mode. The whole-cell patch pipette usually contained (in mM) Cs-gluconate, 130; HEPES, 10; MgCl,, 2; Mg,ATP, 2: Na,GTP, 1: tetraethylammonium (TEA), 2; BAPTA, 0.6; and leupeptin, 0.1 .'Pipette tip resistance was 3-5 Mfi. To elicit high-threshold Ca*+ currents in the whole-cell configuration, we held the cells at around -60 mV and applied voltage steps from -52 to + 12 mV (usually at +8 mV increments). TEA at 20 mM and TTX at 0.75-l PM were added to the extracellular ACSF to block K+ channels and sodium spikes.
SS eficts on I,,, and I, In accord with our previous reports (Moore et al., 1988; Schweitzer et al., 1990 ) superfusion of SS (1 PM) elicited in CA 1 hippocampal pyramidal neurons an outward current with a concomitant increase in Z, amplitude and input conductance (Fig.  3) . The current recording ( Fig. 3 .4) exhibits a slow inward deflection (relaxation) at the onset of each hyperpolarizing step. These relaxations are due to the inactivation of the Z, for the steps positive to -70 mV, and activation of Z9 for the hyperpolarizing steps more negative than -70 mV. Superfusion of SS elicits an outward current in the depolarized range with no effect at more hyperpolarized potentials. A plot of the steadystate current versus voltage (Fig. 3B ) reveals the outward rectifying nature of Z, in the -40 to -70 mV range and the inward rectifying behavior of Z9 in the -70 to -95 mV range. Measurements of the relaxation amplitudes show that SS increases Drug administration. Drugs and peptides were made from a stock solution and added to the ACSF in known concentrations immediately before administration to the slice chamber. The usual drug protocol followed for agonist testing was to record currents during superfusion of ACSF alone ("control"), followed by switching of ACSF with drug and repeating these current measures after 5-l 0 min of drug, then followed bv switchina aaain to ACSF alone for 15-30 min with subsequent current measures F'washout"). The cell was depolarized to about--45 mV for I,., analysis at each of these three periods, but was held near resting potential between these periods to avoid the instabilities that occasionally develop with prolonged depolarization (see Halliwell and Adams, 1982) . For tests of the enzyme inhibitors, because AA and SS did not affect all neurons (roughly 70%) the usual protocol involved first applying the agonist (AA or SS, with measurements as above), and then quickly adding the inhibitor to the agonist superhusate once a (Fig. 3C ), as seen in most neurons (although three cells showed an increase in the lo relaxation).
Of 53 cells tested with SS, 39 responded with an increased ZM amplitude of 55-60% across all voltage commands (Fig. 4A ). This was associated with an outward (steady-state) current shift relative to control (Fig. 4B ) at both resting (61 _+ 8 PA) and depolarized potentials (221 f 20 pA at -43 mV). These effects usually occurred within l-3 min after SS reached the inner slice chamber, with peak responses occurring at 4-6 min. Recovery to control measures usually required about 15 min of SS washout with ACSF alone. Among the 14 neurons that did not show an ZM augmentation with SS, 8 revealed a small outward current in the presence of SS (40-80 pA from -70 to -40 mV holding potentials). b extrapolated SS eflects on depolarization-evoked inward currents We examined the possibility that large inward conductances such as Na+ or Caz+ might be involved in the SS effects, by treating the CA 1 neurons with agents that block these currents. Injection or leakage of QX-3 14, the local anesthetic Na+ channel blocker (Connors and Prince, 1982) , into the cells from pipettes containing high concentrations (50-100 mM) of the drug often appeared to lead to smaller M-current relaxations, suggesting nonspecific actions on K+ channels. Use of pipettes containing a 25 rntvr concentration of the agent had no obvious effect on Z, or other K+ conductances such as those underlying the postburst afterhyperpolarizations (AHPs), but Na+-dependent spikes recorded in current-clamp mode were blocked within 10-l 5 min Voltage (mV) of cell penetration. At this point, increasing the strength of depolarizing current steps evoked broad, slowly developing spikes typical of Ca*+-dependent action potentials (Fig. 54 ). As these spikes were always completely blocked by subsequent superfusion of 200 PM Cd2+, they were likely produced primarily by Ca*+ currents. Subsequent superfusion of TTX (0.5-l NM) had little or not effect on the shape of these spikes.
SS (1 FM) superfusion, whether with or without TTX, had little or no effect on the shape or size of the Ca2+-dependent spikes (Fig. 54 ) in seven of eight neurons (five recorded with pipettes containing 25 mM QX-3 14, two with 50 mM, one with 80 mM). Only one neuron showed a small reversible decrease in the Ca*+-dependent spike. In patch-clamp studies, neurons recorded in the whole-cell configuration using pipettes containing Cs+ and TEA to block K+ channels, and with TEA in the superfusate, showed pronounced inward currents on depolarization from holding potentials of -60 mV with command steps from -44 to + 12 mV. These currents are likely to be carried Effect of SS on current-voltage relationships of a CA1 pyramidal neuron. A, Superimposed current recording of a neuron held at -40 mV and hyperpolarized, by -5 mV incrementally increasing steps, to -95 mV. RMP was -66 mV for this cell. The current relaxation seen from -45 to -70 mV is due to I,; note the outward steady-state current in the depolarized range (broken line, control holding current) and the I, increase observed in the presence of SS (6 min after onset). The relaxation appearing between -75 and -95 mV is due to the anomalous (inward) rectifier or Q-current. B, Plots of instantaneous current (Zinst; see Fig.  2A ) and steady-state current (Zstst) before (control) and during 1 PM SS superfusion, taken from data in A. Note convergence of the Iinst and Istst curves between -70 to -80 mV, indicating lack of SS effect in the hyperpolarized range. C, Curve of voltage dependence of relaxation amplitude (Zinst minus Zstst) measured as in Figure 2A shows I, and ZQ amplitudes, with overlap of the curves from about -75 mV to -95 mV showing that I, is not affected by SS. By contrast, SS elicits separation of the curves from -70 mV into the depolarized (Zh() range.
by Ca*+, because they are activated at around -35 mV, show current-voltage characteristics typical of the high-threshold Ca2+ current (see Fig. 5B ), and are blocked by Cd*+ at 50-200 PM.
Superfusion
of SS at 1 PM had little consistent effect on the amplitude of the inward currents in four of six cells (Fig. 5B ). In the two other cells an apparent small reduction of the currents by SS could not be reversed by washout with ACSF alone; rather, the inward currents continued to get smaller, suggesting a "rundown" effect probably due to the whole-cell recording configuration.
To examine further the possibility that large remote Na+ and/ neuronal responses to depolarizing current injection in current-clamp mode, recorded with a sharp pipette containing QX-3 14 (25 mM) and with TTX 1 PM in the bathing medium. Superfusion of 1 PM SS resulted in a very slight decrease in the amplitude of the Ca*+-dependent action potential that never recovered with washout. RMP was -68 mV. B, Different CA1 pyramidal neuron recorded in the whole-cell, voltageclamp configuration. The patch pipette contained 130 mM Cs-gluconate and 2 mM TEA to block K+ channels; the superfusion medium also contained TEA at 20 mM, and 1 PM TTX to block Na+ channels. Selected inward currents resulting from two (to -12 mV and +6 mV, voltage protocol on lower left) of several (not shown) depolarizing steps from a -60 mV holding potential, subtracted for leak currents. SS superfusion
(1 PM) had no significant effect on the inward currents. RMP = -47 mV (depolarized due to intracellular Cs+ ). -80 -60 -40 Voltage (mV) nonspecific actions of QX-3 14 or Cd*+. Nonetheless, in seven cells with a measurable Z, relaxation (25-50 mM QX-3 14 in the pipette), SS (1 PM) superfusion increased the Z, relaxations in four cells by 25-250% (mean: 105%). The other three cells either showed no change of ZM with SS superfusion or exhibited a slow Z, "rundown" over time.
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CAMP
To examine a possible mediator role of CAMP in the SS-Z, effect, we tested 8-Br-CAMP (0.5-2.5 mM) on six cells. On average, 8-Br-CAMP evoked an early (l-2 min), small (25 PA) outward current, which reversed to a small inward current (-35 PA) after 3-4 min of superfusion. These effects were associated with decreased conductance (8-10%) and a slight (10%) reduction in ZM. One cell showed a small ZM increase (20%) associated with little outward steady-state current. Dibutyryl-CAMP (1 mM) was tested in two cells. One responded with an Z, increase (20%) and an outward steady-state current (70 PA) at depolarized potentials, with recovery on washout. The other cell did not show a measurable response.
Znvolvement of PLA, in SS efects
To test the involvement of the PLA, system (Fig. 1) in the SS effects, we superfused two substances that can inhibit PLA, (see Fig. 1 caption for drug references), 4BPB (10 PM; seven cells) and quinacrine (8 FM; eight cells). Both abolished all SS effects: the augmentation of ZM (Fig. 6A ) and the outward current shift (Fig. 6B ) returned to near control levels. To identify the current effects of these compounds, we subtracted the current-voltage relationship obtained during drug application from that obtained in the control condition. Thus, Figure 6C shows the net outward current elicited by SS, which is fully abolished in the presence of 4BPB. The difference between these two currents is the 4BPB-sensitive component. 4BPB, like quinacrine (data not shown), completely blocked SS-induced effects. Neither 4BPB (four cells) nor quinacrine (four cells) alone in the superfusion medium had a measurable effect on control Z, or steady-state current (data not shown).
We also tested mellitin (1-5 &ml), an activator of PLA, Voltage (mV) Figure 6 . SS effects are blocked by the PLA: inhibitor 4BPB. A, Mean I,, amplitude is increased by SS, and this effect is completely abolished by application of 4BPB together with SS. B, Current-voltage curve showing that the SS-induced outward steady-state current is also completely reversed by concomitant superfusion of 4BPB. C, Graph of net SS induced current before and during 4BPB; data were obtained from B by subtracting the control from the SS and SS+4BPB currents. Unlike NDGA (see Fin. 1 lA), 4BPB reverses all SS effects, as indicated by the 4BPB-sensitive curve (4BPB sens., broken curve).
(Shier, 1979) on four cells. In one cell mellitin increased I, by 23% with a 10% increase in input conductance; in the three other cells, only a slight outward current could be detected (about 30 PA). In all cases, these effects were short-lived (a few minutes) and followed by an inward current without recovery that was associated with either a conductance increase (two cells), decrease (one cell) or no change (one cell).
AA mimics SS

Inhibition
of SS effects by phospholipase inhibitors led us to examine the effects of AA, the initial product of the PLAZ pathway (see Fig. 1 ). Figure 7A shows the current records of a CA1 neuron superfused with AA. In this experiment we superfused ACSF containing 2 mM CsCl to block I,. Like SS, AA elicited 1, augmentation and an outward steady-state current in three of three neurons bathed with 2 mM Cs+. With I, blocked, we were able to determine the I, reversal potential (Fig. 7R) , and estimate the M-conductance variation (Fig. 7C, caption) . The Z, reversal potential was -80 mV for this cell, and the M-conductance increased from 3.7 nS in the control condition to 7 nS in the presence of AA.
In 33 of 45 cells, AA elicited a 55-750/u increase in Z, amplitude (Fig. 8A) , and caused a net outward current at both resting potential (66 * 10 PA) and at depolarized potentials (233 -t 16 pA at ~43 mV) (Fig. 8B) . The time course for these AA effects (l-3 min for response onset; peak effect, 5-6 min; 12-l 5 min for recovery on washout) was equivalent to that for SS. To verify that the AA effect indeed involved I,,, we added CCh, a muscarinic agonist, in the presence of AA. As shown in Figure 8C , CCh (25 PM) blocked ZM and the concomitant outward current produced by AA, supporting the notion that M-channels are the source of the relaxation increase. as previously demonstrated for SS (Moore et al.. 1988) . Of the 12 neurons in which AA did not modify I,, six exhibited an AAinduced outward current (40-90 pA from -70 to -40 mV holding potentials).
This current amplitude was equivalent to that induced by SS in neurons in which SS did not increase I,.
SS and AA increase M-current time constant
The time constant (7) of the I, relaxation increased with superfusion of either SS or AA. This augmentation reached significance (P < 0.00 1 for SS, P < 0.002 for AA; Student's t test) when averaged across 32 SS-and 28 AA-responding cells (Fig.  9) . Average control T values at ~53 mV (during a 10 mV hyperpolarizing step from -43 mV holding potential) were 173 f 12 msec (mean + SEM) for the group subsequently tested with SS and 177 * 13 msec for the AA group, diminishing with further hyperpolarization as previously described (Adams and Brown, 1982; Halliwell and Adams, 1982) . Mean 7 (at the same average membrane potential, ~ 53 mV) increased to 2 19 +-17 msec with superfusion of SS (a 20-27% increase across all four voltage steps; mean, 24%) and 218 * 18 msec with AA (23-3 1% increase across the four voltage steps; mean, 27%). The average r returned to near control levels on washout. Interestingly, all drugs blocking I, augmentation (PLA? and LOX inhibitors: see sections on LOXs below) also abolished the 7 increase.
COX pathway
A major route for AA metabolism is the COX pathway, leading to formation ofprostaglandins and thromboxanes (Fig. 1) Voltage (mV) (n = 4) or AA-(n = 4) induced ZM augmentation did not cause any measurable effect (e.g., Z, potentiation). Indomethacin alone had no effect on Z, relaxations or steady-state current (three cells). We further investigated a possible involvement of the COX pathway by testing the prostanoids, prostaglandin E, (PGE,), PGF,,, oy PGI,. PGE, (20-60 PM; three cells) had no effect on two cells and provoked a small inward current (30 PA) in one cell with an input conductance decrease of 20% but no effect on Z,. PGF,, (2-3 NM; two cells) superfusion also caused a small depolarization in one cell with a 15% decrease in input conductance without affecting Z,. There was no PGF,, effect on the other cell. Both cells tested with PGI, responded with some inward current at depolarized potentials; one exhibited a 35% decrease in Z,. Thus, COX products did not consistently alter Voltage (mV) Voltage (mV) the CA 1 pyramidal neuron current-voltage relationships; rather, the effects observed involved a small inward current with no change in ZM.
LOX pathways LOXs provide other routes for AA metabolism. Superfusion of NDGA (10 PM), a general inhibitor of LOXs, had no significant effect when applied alone (n = 4). However, it abolished both the SS-induced (7 of 8 cells) and the AA-induced (11 of 11 cells) ZM augmentation (Fig. lOA) , bringing Z, amplitudes back to control level. Nonetheless, NDGA superfusion did not completely reverse the overall SS-or AA-induced net outward current ( Fig. 10B) : a residual outward current remained with both SS and AA at the potentials tested. To separate these different components, we subtracted the current-voltage curve during NDGA application from the control curve, as described for 4BPB. Figure 11A shows the net outward currents elicited by SS (left panel) or AA (right panel) alone and in the presence of NDGA (contrast to Fig. 6C) . The difference between these two currents reveals the component blocked by NDGA, that is, the NDGA-sensitive current (broken lines in Fig. 1 IA) . Figure 11B shows the conductance calculations relative to this NDGA-sensitive current: it activates at about -65 mV, shows voltage dependency, and exhibits a net conductance augmentation of about 3.5-4 nS around -40 mV (Fig. 11B) ; the extrapolated reversal potential is estimated to be -82 mV with SS and -83 mV with AA. Thus, addition of NDGA inhibits SS-or AAinduced IM augmentation and much of the induced outward current (15-200 pA over the voltages tested), and reveals a residual SS-or AA-induced outward current of about 30-50 pA remaining over the same range of potentials. We also tested NDGA on those few neurons in which superfusion of SS or AA did not increase Z, but still induced a small outward current. In these cells, NDGA did not antagonize the SS (n = 3) or AA (n = 2) effects. and is completely reversed after washout of the lipid. C, I, relaxations, their increase by AA, and the AA induced outward steady-state current (broken lines) are all completely blocked by CCh, a muscarinic agonist. CCh also causes an additional steadystate inward current. These effects of CCh began within 1 min after the perfusate reached the slice chamber (peak effect within 2 min); recovery to control levels required 15-20 min of washout with ACSF alone (see Pontzer et al.. 1992) . RMP was -70 mV.
12-LOX Because 12-LOX-like immunoreactivity recently has been shown to exist in canine hippocampus (Nishiyama et al., 1992) we tested the effect of the specific 12-LOX inhibitor baicalein (4 PM) on SS responses. Baicalein affected neither the SS-induced outward steady-state current nor the I, increase in the five pyramidal neurons tested (Fig. 12) . We also tested the primary metabolite of the 12-LOX pathway, 12-hydroperoxyeicosatetraenoic acid (12-HPETE). In five cells examined, two exhibited an outward current but without change in IM amplitude. The three remaining cells did not exhibit any measurable effect.
Involvement of 5-LOX and leukotrienes in I, increase
To investigate further the LOX pathways, we superfused two specific 5-LOX inhibitors, 5,6-methanoleukotriene A, methylester (MLTA, 10 PM) and 5,6-dehydroarachidonicacid (DHAA, 10 PM). Both substances completely blocked the I,-augmenting effects of SS (five cells; Fig. 13A,B) and AA (four cells ; Fig. 13B) ; however, like NDGA, they did not fully reverse the overall SS- Figs. 1 lA, 13C ). The involvement of the 5-LOX pathway in Z, augmentation led us to test the leukotrienes. The initial product, leukotriene A, (LTA,), can be transformed to LTB, or LTC,. Superfusion of LTC, (5-8 PM), even in the presence of NDGA (coperfused to prevent endogenous generation of AA metabolites), mimicked the action of SS and AA in augmenting both Z, and input conductance, and in eliciting an outward steady-state current at depolarized potentials (four of five cells; Fig. 14) . LTB, (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) had no significant effect on these measures in three of four cells (data not shown), although it clearly increased Z, in one cell. Discussion SS hyperpolarizes central neurons in several preparations by activating a K+ conductance. This K+ current is outwardly rectifying in solitary tract complex (STC) (Jacquin et al., 1988) , hippocampus (Schweitzer et al., 1990) , and neocortex (Wang et al., 1989) and involves ZM in the STC and hippocampus but not in the neocortex. SS acts on an inward-rectifying conductance in locus coeruleus (Inoue et al., 1988) and possibly in dorsolateral septal nucleus (Twery and Gallagher, 1989) . In the present study, we have analyzed the overall effects of SS in hippocampal pyramidal neurons and have (1) quantified the SS augmentation of Z, and the outward rectification, and detected an increase in its kinetics by SS and AA, (2) performed studies that largely exclude SS actions on some other conductances; (3) uncovered another outward-current effect of SS in hippocampus that may be activated by AA itself; and (4) provided further evidence for mediation of the ZM effect by an AA metabolite, probably a leukotriene.
Selectivity of SS effects on the M-current Three major points demonstrate that the Z, effect of SS does not arise from actions on IQ: (1) in contrast to IQ, the SS-enhanced inward I,., relaxations are larger at more depolarized potentials and show a greater ohmic step at hyperpolarizing command onset than at command offset; (2) Cs+ blocks la but not ZM nor the augmenting effect of SS on Z,; (3) CCh (and Ba+; Moore et al., 1988) block the Z, relaxation and its augmentation by SS, but not the la relaxation. Another potential site of action of SS is on an anomalous or inwardly rectifying K+ current that could be distinct from IQ. Such inward rectifying currents are increased in some central neurons by SS, but these currents are sensitive to Cs+ (Inoue et al., 1988) . Indeed, we now have evidence that both SS and AA can elicit an outward current with properties distinct from Z,. However, this current is rather small (30-50 PA), and current-voltage relationships before and during SS superfusion do not show much difference in the hyperpolarized voltage range. This contrasts with the effects of the GA-BA, receptor agonist baclofen, which augments inward rectification and elicits a pronounced divergence of the current-voltage curves in the hyperpolarized range (S. Madamba and G. R. S&gins, unpublished observations; see Andrade et al., 1986) . SS has also been shown to increase an outward K+ current in neocortical neurons in culture (Wang et al., 1989) . However, this effect is insensitive to CCh, whereas the SS effect in hippocampus is blocked by this muscarinic agonist.
Other possible sites of SS action are large inward currents carried by, for example, Caz+ or Na+, also possibly unclamped at remote (dendritic) sites. SS has been reported to diminish Caz+ currents in cell lines (Ikeda and Schofield, 1989) and, more recently, in neocortical neurons in culture (Wang et al., 1990) . AA has also been reported to inhibit Ca2+ currents in CA1 et al. Hyperpolarizing step (mV) Figure 12 . Effect of baicalein (Bai), a 12-LOX inhibitor, on SS effects. A, Current records: baicalein 4 PM, added for 7 min to the perfusate containing SS, does not alter the SS-induced ZM or conductance increase, or the outward steady-state current. Subsequent washout of both SS and baicalein with ACSF alone for 16 min reverses the SS effects. B, Plots of average Z, relaxations obtained with several different voltage commands. Baicalein did not reduce the SS-induced I, increase in any of these five cells. In four of these cells, baicalein was applied after SS as in A. In one of these cells, baicalein was applied for 8 min before the coadministration of SS; this cell also showed no alteration of the SS induced Zhl increase. Washout of all drugs returned the mean ZM to control levels.
neurons in culture, possibly via protein kinase C activation (Keyser and Alger, 1990 ). However, in our studies, CA1 pyramidal neurons still showed SS augmentation of Z, after blockade of Na+-and Ca2+-dependent spikes with TTX, QX-314, and Cd2+. Furthermore, our observations that SS did not consistently alter Ca*+-dependent spikes in current clamp, or the inward currents (thought to be IL) evoked by depolarizing commands in the whole-cell configuration, also argue against a SS effect on Ca2+ conductances. Another possible site of SS action is on conductances underlying the posttrain AHP, such as ZAHP or I,. However, in previous studies we did not see a consistent effect of SS on the AHPs themselves (Moore et al., 1988) . Furthermore, SS effects and ZM itself, but not I, (Madison et al., 1987) , are blocked by CCh. In the present study, superfusion of CdZ+, known to block several types of AHP currents (as well as other Ca*+-dependent precesses), did not alter SS-induced Z, increases. Nonetheless, a thorough voltage-clamp ("hybrid-clamp") study of the underlying currents has not been carried out, partly because of the likelihood that there will also be a contribution of ZM to such conductances (Storm, 1989) . Thus, we cannot completely eliminate the possibility that an AHP current is involved.
Second messenger mediation of SS eflects SS has been shown to inhibit adenylate cyclase in many preparations (see, e.g., Chneiweiss et al., 1985; Wang et al, 1989) . Thus, CAMP would seem an obvious candidate for mediation of SS effects. However, analogs of CAMP did not markedly alter resting properties or the I,,,, of CA1 cells in our studies. They induced a small inward current similar to that previously described for hippocampal neurons . Alternatively, the early, small steady-state outward current elicited by 8-Br-CAMP could be due to a brief effect on extracellular adenosine receptors. It should be noted that the electrophysiological effects of SS in neocortical neurons described by Wang et al. (1989) also were independent of CAMP.
Thus, CAMP does not seem to be involved in the mediation of SS-effects in hippocampus. Other investigators have examined the role of additional second messenger systems in Z, regulation. Diacylglycerol and protein kinase C do not affect ZM , but inositol triphosphate, a product of PLC, has been shown to decrease ZM and is thought to be the mediator for the muscarinic inactivation of Z, (Dutar and Ni-~011, 1988) . A role for intracellular Ca2+ in ZM regulation is also now becoming apparent (see Further aspects of second messenger mediation, below).
AA and its metabolites mediate SS efects. Our combined data (see also Schweitzer et al., 1990) implicates AA and its metabolites as strong candidates for mediation of SS effects. The parallel mimicry of all SS effects by exogenously applied AA is consistent with a role for AA as an intracellular mediator. Thus, SS and AA superfusion augments Z, amplitude (55-60% and 55-75%, respectively) and kinetics (20-27% and 23-31%, respectively) to the same extent. SS and AA elicit a similar outward steady-state current increasing with depolarization (22 1 pA and 233 pA, respectively, at -43 mV holding potential). Although it could be argued that the concentration of AA we used is high, it should be noted that because of the adsorption of fatty acids, the actual concentrations of AA surrounding the cell in our experiments are certainly lower than the calculated concentrations in the chambers. It is likely that the amount of AA gaining access to the neuronal membrane is < 5% of that in the buffer (Freeman et al., 1990) . Thus, presumably less than 6 PM AA reached the neuronal membrane.
Our other pharmacological findings further support the involvement of AA in mediating SS effects. Thus, both the PLA, inhibitors 4BPB and quinacrine completely blocked all the SS effects. The antagonism appeared identical, in spite of differences in the site of action of each of these inhibitors: 4BPB inhibits PLA, (but not PLC in hippocampus; see Okada et al., 1989) by binding to the enzyme, whereas quinacrine interacts with the phospholipid substrate (see Blackwell and Flower, 1983) . However, the PLA, activator mellitin did not elicit a consistent effect on Z,, but evoked a delayed dramatic inward current without recovery, possibly due to a lysis of the membrane lipids by mellitin (see Katsu et al., 1989) . Further support of the role for AA in SS effects is a recent report showing that SS activates PLA, and AA release in astrocytes (Marin et al., 199 1) .
LOX metabolites mediate I,,, augmentation. Our studies of the AA pathways suggest a role for LOX metabolites of AA in the SS-Z, effect. The LOX inhibitor NDGA completely antagonizes SS-and AA-induced Z, augmentation. Concomitantly, NDGA greatly reduces the SS-and AA-induced outward steadystate current. Thus, it seems that the NDGA-sensitive outward steady-state current is entirely due to ZM, since the threshold of activation, voltage dependency, and NDGA blockade of this outward current correlate with these properties of the Z,. Furthermore, our conductance calculations reveal an increase of M-conductance of 3-4 nS with AA (Fig. 7C) or SS (Schweitzer et al., 1990) values very similar to those found for the SS-or AA-induced outward current sensitive to NDGA (Fig. 11B) . The different inhibitors of the AA cascade we used only blocked the SS-induced outward current and ZM increase, without affecting the basal currents. Thus, AA and its metabolites may be involwed only in the SS effects and do not seem to control resting properties.
There are several LOXs; the two major ones are 5-LOX and 12-LOX. Our findings that specific 5-LOX but not 12-LOX inhibitors antagonize both SS-and AA-induced ZM effects are consistent with mediation of SS-Z, effects by 5-LOX metabolites. As with NDGA, a residual outward current remains when 5-LOX blockers are added together with SS or AA, suggesting again some effect of AA itself. The role of 5-LOX and leukotrienes in the SS-Z, effect is supported further by our finding that LTC, application leads to Zhl effects similar to those obtained with AA and SS. Leukotrienes are synthesized in several brain regions, including hippocampus (Dembinska-Kiec et al., 1984; Lindgren et al., 1984) . LTC, can be metabolized further to LTD, and LTE, (reviewed by Samuelsson et al., 1987) , which could also be involved in the SS-Z, effect. However, binding sites for LTB, and LTE, are weak and those for LTD, undetectable, suggesting that LTC, may represent the most active metabolite in brain. Interestingly, specific LTC, binding sites are found in several brain areas and are among the most numerous in brainstem and hippocampus (Schalling et al., 1986) , the two areas where SS has been shown to increase ZM (Jacquin et al., 1988; Moore et al., 1988) .
The 12-LOX metabolites have been shown to be involved in FMRFamide and histamine effects in Aplysia (Piomelli et al., 1987a,b) . Here, the FMRFamide effect could be mediated directly by 12-HPETE (Buttner et al., 1989) or a heme-catalyzed product (Belardetti et al., 1989) . However, in our experiments, the 12-LOX inhibitor baicalein had no effect on SS responses. In accord with this finding, super-fusion of the 12-LOX product 12-HPETE gave inconsistent results, and in no case did it alter ZM. Still, given the transient chemical nature of this short-lived intermediate metabolite (Piomelli and Greengard, 1990) compared to AA and LTC, (Samuelsson et al., 1987) conclusions regarding these negative findings should be tentative when using a brain slice preparation, where drugs need l-2 min to reach the recorded cell. Other studies have shown that AA causes hyperpolarization and increased posttrain AHP size in CA1 hippocampal neurons, but without change in input resistance (Carlen et al., 1989) . These effects were reproduced by the peptidy1 form of 8-HEpETE (8-hydroxy-11,12-epoxy-5,9,14-icosatrienoic acid or hepoxillin A,), a 12-LOX metabolite, although without recovery on washout. Interestingly, the formation of this compound is analogous to that of LTC,, in that both products are produced by a glutathione-conjugating system (PaceAsciak et al., 1990) .
A second SS efict. Effects of the LOX inhibitor NDGA, as well as MLTA and DHAA, also reveal that SS acts on another conductance. The persistence of a small current in the presence of LOX inhibitors and the lack of effect of the COX inhibitor indomethacin suggest that this effect is not mediated by an AA metabolite, but most likely by the fatty acid itself. AA and certain fatty acids have been shown to alter electrophysiological cell properties in peripheral tissues by acting on ionic currents (reviewed by Ordway et al., 1991) . Therefore, the NDGA-resistant hyperpolarizing effect of AA could be due to a direct interaction with a channel or alteration of the membrane lipid bilayer. This current is rather small but appears to play a major role in the hyperpolarizing effect seen at rest. Interestingly, the hyperpolarizing effect (40-90 pA outward current) of SS and AA on a few neurons not responding with Z, augmentation resembles the NDGA-resistant current, and indeed also was resistant to LOX and COX inhibition. The properties of the NDGA-resistant current are still unclear: it could be an inwardly rectifying current, or perhaps a leak current such as that reduced by muscarinic agonists in hippocampal neurons (Madison et al., 1987) . The unusual nonlinearity of this current could also be related to some uncharacterized dendritic conductance (see Benson et al., 1988) . In fact, it is possible that if the underlying conductance is generated far away on the dendritic tree, it may not be properly clamped, especially in the depolarized potentials.
We also examined a possible role of the COX pathway. The lack of effect of the prostaglandins as well as indomethacin alone on ZM suggests that COX metabolites are probably not linked to the ZM augmentations elicited by SS or AA. Interestingly, indomethacin has been shown to increase LTC, levels in rat brain (Dembinska-Kiec et al., 1984) . Thus, the potentiations we saw with indomethacin applied together with SS or AA could arise from COX inhibition, leading to shunting of increased AA toward the LOX pathway (see Higgs and Vane, 1983) . However, we cannot disregard a possible effect on Z, of some other COX metabolites not yet tested, or possible inhibitory effects of prostanoids on the LOX pathway. A dual role of COX and LOX metabolites has been described for the modulation of an inwardly rectifying K+ current in atria1 cells (Scherer and Breitwieser, 1990 ). The partial later inhibition of SS effects by indomethacin we saw in some cells may reflect nonspecific inhibition of PLA, (Irvine, 1982) , since long indomethacin superfusions never reduced AA-induced ZM increase.
The data reported here and elsewhere (Schweitzer et al., 1990 ) provide new electrophysiological evidence for eicosanoid mediation of a transmitter effect in a vertebrate central neuron. Piomelli et al. (1987a,b) previously showed that 12-LOX metabolites may mediate FMRFamide effects on a K+ current, and hyperpolarizations elicited by histamine, in Aplysia neurons.
Prostaglandins have been implicated in mediation of vasoactive intestinal peptide (VIP) biochemical effects in brain slices (Schaad et al., 1987) , whereas LOX products may regulate VIP release (Martin and Magistretti, 1989) . Similarly, a product of the epoxygenase pathway for AA, 5,6-epoxyeicosatrienoic acid, induces SS release in hypothalamus (Capdevila et al., 1983) . Thus, as with VIP, two different AA pathways appear to be involved in the release of SS on the one hand and its electrophysiological effects on the other.
M-current kinetics. Considering that our studies were done at a higher temperature, the Z, time constant (7) values in the present study are consistent with those of Halliwell and Adams (1982) . These authors reported values of 267-303 msec at -50 mV and 118-176 msec at -60 mV (temperature of 23°C) in guinea pig hippocampus, with a Q,, of about 5 around 25°C. We found that both SS and AA significantly increased 7 for the 1, relaxations in CA1 pyramidal neurons. The increase with SS or AA compared to control conditions did not reach significance in our previous report (Schweitzer et al., 1990) because of the variability in T-values and the smaller number of cells in our earlier sample. Interestingly, the Z, increase evoked by isoproterenol in smooth muscle is also associated with a 7 increase (Sims et al., 1988) , as is the I, augmentation (termed overrecovery) observed on washout of muscarine in sympathetic neurons 199 1) . The r increase for IM we observe in pyramidal neurons with both SS and AA might represent a change of M-channel properties due to a variation in intracellular Ca2+ concentrations (see Marrion et al., 1991) . The isoproterenol effect on T in smooth muscle cells appears to be mediated by CAMP, and is postulated to reflect a decrease in the closing rate constant for M-channels (Sims et al., 1988) .
Further aspects of second messenger mediation Using fura-measurements, Marrion et al. (199 1) observed that Z, augmentation (over-recovery) in sympathetic ganglia after muscarine washout is associated with a moderate increase of intracellular Ca*+ concentration (higher internal Ca2+ elevation blocks ZM). It is possible that in a process of muscarinic activation of both PLC and PLA, (Kanterman et al., 1990) where internal Ca*+ would rise and then fall, PLC may inactivate first because of a lower sensitivity to intracellular Ca*+ than PLA,. This would reveal a transient, exclusive PLA, effect (the "overrecovery"), before inactivation of this enzyme as the internal Caz+ concentration returns to basal levels. More recent data also have shown augmentation of ZM by intracellular Caz+ injection; this effect is blocked by NDGA and mimicked by AA (Yu et al., 1991) . Thus, internal Ca2+ seems to play a key role in 1, regulation, especially when considering possible differential sensitivities to Ca2+ of the enzymes that may be involved (PLA,, PLC, protein kinase C), acting in opposite directions through the metabolites they generate (in hippocampal CA1 neurons, PLC and inositol triphosphate vs PLA, and AA metabolites).
It is also possible that a GTP-binding protein may be involved in the SS activation of PLA, (North, 1989; Axelrod, 1990) . Biochemical studies have shown that SS receptors are linked to G-proteins in brain (see Law et al. 1991) . Further studies will be required to determine if the SS effects described here involve one or more G-proteins. Furthermore, the exact metabolite or metabolites involved in hippocampal SS effects on ZM are not known, although our data with LTC, suggest that a leukotriene is the best candidate. Additional support of this idea must await localization (e.g., by immunocytochemistry or in situ hybridization) of the relevant enzymes or their products in hippocampal neurons. Given their great membrane permeability, eicosanoids, unlike most other messengers, can leave the cell in which they are generated and act as first messengers on neighboring cells (Piomelli et al., 1987a; Piomelli and Greengard, 1990; Shimizu and Wolfe, 1990 ). Thus, they could act on the M-channels and other conductances by either an intracellular or an extracellular route. Therefore, presynaptic or feedback effects cannot be excluded. Studies using intracellular drug application are planned to evaluate these alternatives.
In this regard, there is now considerable evidence that AA and/or PLA, (and possibly some LOX metabolites) play some role in hippocampal CA1 long-term potentiation (LTP), the electrophysiological model of learning and memory. Thus, (1) AA produces a long-lasting enhancement of synaptic transmission Drapeau et al., 1990) and increases NMDA currents (Miller et al., 1992) ; (2) inhibitors of PLA, can prevent expression of LTP (Okada et al., 1989; Drapeau et al., 1990) ; and (3) both NMDA (thought to be the trigger for LTP) and LTP itself increase the release and postsynaptic membrane levels of AA in hippocampal tissue (Sanfeliu et al., 1990; Clements et al., 199 1) . The view of some researchers (see, e.g., Clements et al., 1991) is that AA or a metabolite is generated postsynaptically but diffuses to presynaptic glutaminergic terminals to enhance transmitter release (but see O'Dell et al., 199 1, for another mechanism involving nitric oxide). Although our findings of inhibitory (hyperpolarizing) effects of AA and LTC, are not entirely consistent with enhancement of synaptic transmission, the AA metabolite(s) may have a different effect on presynaptic terminals or elsewhere than at postsynaptic CA1 pyramidal neurons. The recent finding that AA (and also SS via PLA,; Mat-in et al., 1991) causes a prolonged inhibition of glutamate uptake into glia (Barbour et al., 1989 ) is consistent with this interpretation.
The exact physiological role and sites of action of the relevant lipid(s) in hippocampus cannot be stated at this time. However, our findings do suggest that, as in some invertebrate neurons (Piomelli et al., 1987a; Belardetti and Siegelbaum, 1988) , a single ion channel type (the M-channel) in mammalian central neurons can be regulated in opposing or reciprocal directions by two different ligands-SS and ACh-acting through different second messenger systems. These bidirectional regulatory mechanisms should provide sensitive biasing of ion channel activity, and thus of neuronal excitability. Possible cross-talk between the intracellular mediators adds further complexity. In addition, the present studies now suggest a second SS-sensitive conductance (NDGA resistant) in most of the same cells exhibiting IM augmentation. Hence, in these cells SS receptors may not only converge with another receptor class (muscarinic) onto a single channel type; SS may also diverge to act on another SS-receptorion channel system with different, but still hyperpolarizing, properties. This latter SS substrate appears to require at least one less enzyme for its function than the M-channel effect, and therefore may be subject to quite different regulatory factors.
